Shorter daily dwelling time in peritoneal dialysis attenuates the epithelial-to-mesenchymal transition of mesothelial cells

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Lee, Yi Che ^a,c   Tsai, Yau Sheng ^c   Hung, Shih Yuan ^a,b   Lin, Tsun Mei ^a   Lin, Sheng Hsiang ^c   Liou, Hung Hsiang ^f   Liu, Hsiang Chun ^d   Chang, Min Yu ^a   Wang, Hsi Hao ^a   Ho, Li Chun ^a,c   Chen, Yi Ting ^a   Chen, Hsin Pao ^a   Fan, Hong Arh ^a   Liu, Kuang Wen ^a   Kung, Yung Tang ^a   Wang, Hao Kuang ^a   Chiou, Yuan Yow ^c,e  

^a E DA HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f Hsin Jen Hospital   (Taiwan)

Author keywords

Dwelling time; Epithelial to mesenchymal transition; Mesothelial cells; Peritoneal dialysis

Indexed keywords

CYTOKERATIN 18; ALBUMIN; CELL PROTEIN; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; UVOMORULIN;

ADULT; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; DIALYSATE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; IN VITRO STUDY; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MESOTHELIUM CELL; OMENTUM; PERITONEAL DIALYSIS; PROTEIN EXPRESSION; AGE; ALBUMIN BLOOD LEVEL; BODY MASS; CELL SURVIVAL; DIABETES MELLITUS; EFFLUENT; GENDER; GLUCOSE TOLERANCE TEST; HEMOGLOBIN BLOOD LEVEL; HUMAN CELL; HYPERTENSION; KIDNEY FUNCTION; PERITONITIS; TIME; TREATMENT DURATION;

CELL DIFFERENTIATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899050929     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-35     Document Type: Article

References (26)

1. Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Huang CC, Cheng KF, Wu HD, Perit Dial Int 2008 28 Suppl 3 15 S20 18552246
2. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E, Arch Intern Med 2011 171 2 110 118 20876398
3. Current practice of peritoneal dialysis in children: results of a longitudinal survey. Mid European Pediatric Peritoneal Dialysis Study group (MEPPS). Schaefer F, Klaus G, Muller-Wiefel DE, Mehls O, Perit Dial Int 1999 19 Suppl 2 445 S449 10406562
4. Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, Kang SW, Choi KH, Han DS, Lee HY, Perit Dial Int 2007 27 4 432 440 17602152 (Pubitemid 47202196)
5. Is technique survival on peritoneal dialysis better in Japan? Nakamoto H, Kawaguchi Y, Suzuki H, Perit Dial Int 2006 26 2 136 143 16623414 (Pubitemid 44336160)
6. The peritoneal membrane in chronic peritoneal dialysis. Krediet RT, Kidney Int 1999 55 1 341 356 10.1046/j.1523-1755.1999.00264.x 9893150 (Pubitemid 29004273)
7. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. Davies SJ, Phillips L, Naish PF, Russell GI, J Am Soc Nephrol 2001 12 5 1046 1051 11316864 (Pubitemid 32378346)
8. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Lopez-Cabrera M, Aguilera A, Aroeira LS, Ramirez-Huesca M, Perez-Lozano ML, Jimenez-Heffernan JA, Bajo MA, del Peso G, Sanchez-Tomero JA, Selgas R, Perit Dial Int 2006 26 1 26 34 16538870 (Pubitemid 44339656)
9. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents. Vargha R, Endemann M, Kratochwill K, Riesenhuber A, Wick N, Krachler AM, Malaga-Dieguez L, Aufricht C, Nephrol Dial Transplant 2006 21 10 2943 2947 10.1093/ndt/gfl355 16861732 (Pubitemid 44542254)
10. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, Aguilera A, Sanchez-Tomero JA, Bajo MA, Alvarez V, Castro A, del Peso G, Cirujeda A, Gamallo C, Sánchez- Madrid F, López-Cabrera M, N Engl J Med 2003 348 5 403 413 10.1056/NEJMoa020809 12556543 (Pubitemid 36159357)
11. Mediators of inflammation and fibrosis. Lai KN, Tang SC, Leung JC, Perit Dial Int 2007 27 Suppl 2 65 S71 17556333
12. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Aroeira LS, Aguilera A, Selgas R, Ramirez-Huesca M, Perez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sanchez-Tomero JA, Jimenez-Heffernan JA, López-Cabrera M, Am J Kidney Dis 2005 46 5 938 948 10.1053/j.ajkd.2005.08.011 16253736 (Pubitemid 41505470)
13. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, Jimenez-Heffernan JA, Selgas R, Lopez-Cabrera M, J Am Soc Nephrol 2007 18 7 2004 2013 10.1681/ASN.2006111292 17568021 (Pubitemid 47041064)
14. Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Del Peso G, Jimenez-Heffernan JA, Bajo MA, Aroeira LS, Aguilera A, Fernandez-Perpen A, Cirugeda A, Castro MJ, de Gracia R, Sanchez-Villanueva R, Sánchez-Tomero JA, López-Cabrera M, Kidney Int Suppl 2008 108 26 S33 18379544
15. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to- mesenchymal transition in continuous ambulatory peritoneal dialysis. Do JY, Kim YL, Park JW, Chang KA, Lee SH, Ryu DH, Kim CD, Park SH, Yoon KW, Perit Dial Int 2008 28 Suppl 3 101 S106 18552237
16. Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane. Aroeira LS, Lara-Pezzi E, Loureiro J, Aguilera A, Ramirez-Huesca M, Gonzalez-Mateo G, Perez-Lozano ML, Albar-Vizcaino P, Bajo MA, del Peso G, Sánchez-Tomero JA, Jiménez-Heffernan JA, Selgas R, López-Cabrera M, J Am Soc Nephrol 2009 20 3 582 592 10.1681/ASN. 2008020211 19158357
17. Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. Bajo MA, Perez-Lozano ML, Albar-Vizcaino P, del Peso G, Castro MJ, Gonzalez-Mateo G, Fernandez-Perpen A, Aguilera A, Sanchez-Villanueva R, Sanchez-Tomero JA, López-Cabrera M, Peter ME, Passlick-Deetjen J, Selgas R, Nephrol Dial Transplant 2011 26 1 282 291 10.1093/ndt/gfq357 20571097
18. The effect of low glucose degradation product dialysis solution on epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis patients. Do JY, Kim YL, Park JW, Cho KH, Kim TW, Yoon KW, Kim CD, Park SH, Han JH, Song IH, Perit Dial Int 2005 25 Suppl 3 22 S25 16048250
19. An SV40-immortalized human corneal epithelial cell line and its characterization. Araki-Sasaki K, Ohashi Y, Sasabe T, Hayashi K, Watanabe H, Tano Y, Handa H, Invest Ophthalmol Vis Sci 1995 36 3 614 621 7534282
20. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. Yanez-Mo M, Alfranca A, Cabanas C, Marazuela M, Tejedor R, Ursa MA, Ashman LK, de Landazuri MO, Sanchez-Madrid F, J Cell Biol 1998 141 3 791 804 10.1083/jcb.141.3.791 9566977 (Pubitemid 28217922)
21. Twist overexpression promoted epithelial-to-mesenchymal transition of human peritoneal mesothelial cells under high glucose. Li C, Ren Y, Jia X, Liang P, Lou W, He L, Li M, Sun S, Wang H, Nephrol Dial Transplant 2012 27 11 4119 4124 10.1093/ndt/gfs049 22498918
22. Fibrin-induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline. Fang CC, Huang JW, Shyu RS, Yen CJ, Shiao CH, Chiang CK, Hu RH, Tsai TJ, PLoS One 2012 7 9 44765 10.1371/journal.pone.0044765 23028611
23. How to avoid glucose degradation products in peritoneal dialysis fluids. Erixon M, Wieslander A, Linden T, Carlsson O, Forsback G, Svensson E, Jonsson JA, Kjellstrand P, Perit Dial Int 2006 26 4 490 497 16881345 (Pubitemid 44339982)
24. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Ha H, Yu MR, Choi HN, Cha MK, Kang HS, Kim MH, Lee HB, Perit Dial Int 2000 20 Suppl 5 10 S18 11229606
25. HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. Yu MA, Shin KS, Kim JH, Kim YI, Chung SS, Park SH, Kim YL, Kang DH, J Am Soc Nephrol 2009 20 3 567 581 10.1681/ASN.2008040424 19193779
26. Are ex vivo mesothelial cells representative of the in vivo transition from epithelial-to-mesenchymal cells in peritoneal membrane? Cho JH, Do JY, Oh EJ, Ryu HM, Park SY, Kim SO, Hyun SH, Seo HJ, Kim GH, Choi JY, Kim CD, Park SH, Kim YL, Nephrol Dial Transplant 2012 27 5 1768 1779 10.1093/ndt/gfr604 22025117